All News

The ASI-MV is one of several tools that Inflexxion uses to provide real-time, product-specific data to substance-abuse facilities nationwide. The tools are part of the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO), a system designed to shed more light on substance-abuse issues and prescription painkiller addictions.

A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.

Several healthcare groups involved in making and dispensing pharmaceuticals have partnered to create Rx Response-a program designed to help support the continued delivery of drugs during a public health emergency.

Reclast (zoledronic acid injection, Novartis) has been approved by the FDA as the first once-yearly treatment for women with postmenopausal osteoporosis.

Information on how genetic variations can affect a patient's response to warfarin must now be included on the drug's label, according to the FDA.

"Fast start, slow finish." That's how Douglas Long characterized the U.S. pharmaceutical market over the past year, ending in June 2007.

The FDA has proposed a new regulation that sets standards for OTC sunscreen products.

CMS has announced its intention to implement a new rule requiring tamper-resistant prescription pads for Medicaid Rxs beginning Oct. 1.

The author calls for a transparent system for reimbursing pharmacists for their drugs and services that takes into account their operating costs and allows for cost-of-dispensing adjustments.

New drug approvals for branded drugs, generics, plus OTCs, home health care, health and beauty, etc.

Chlorofluorocarbons substances responsible for thinning the ozone layer, have been almost phased out of use. A few uses deemed essential are still allowed, including some inhalers for asthma and chronic obstructive pulmonary disease.

The Consumer Healthcare Products Association is providing educational programs to stop DXM abuse in teens. It also discusses what manufacturers are voluntarily doing to stop teens from purchasing large quantities of cough and cold medicines which contain the ingredients dextromethorphan.

Concerns over the drug diversion and the impact of pharmaceuticals on the environment converge as federal and health experts look for new models to control the impact of unused drugs.

A miscalculation in a prescription for Zinc slipped through the hands of three pharmacists and several nurses at a Las Vegas hospital and led to the death of a premature baby girl last fall. The error prompted the hospital to implement several changes to its policy and procedures for filling TPNs.

Pharmacists begin to organize into trade associations.

OIG plans to continue their investigation into differences between the retail and chain pharmacy participation in Part D. They intend to examine reimbursements to independent and chain pharmacies for specific drug products and to compare the terms of the contracts offered to chains and independent pharmacies.

New tools are available for independent pharmacies for better business management.

A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.

Opinions are divided over how to dispose of unwanted drugs that minimize damage to the environment.

CMS thinks AMP is a reasonable way to reimburse pharmacists for generic drugs if states do their part, but NACDS claims the new methodology pays pharmacists below cost.

A federal judge certified a class-action lawsuit that accuses North America's largest pharmaceutical distributor of inflating wholesale drug prices.

ASHP voiced its support this week for legislation that reauthorizes FDA prescription drug user fees. I

ASHP is urging the World Medical Association to use pharmacists and other allied healthcare professionals more frequently as research investigators.

By 2010, half of all FDA drug approvals will be in the area of specialty drugs.

Pharmacy schools are reporting an acute shortage of faculty members.

Shaughnessy joins AMCP; APhA names new governance director

MSLs provide information and education to insurers and doctors but differ from sales representatives in their ability to provide peer-level interaction.

Medco claims that PolyMedica Corp. is the nation's largest provider of blood glucose testing supplies and related services to people with diabetes.

The grants are designed to reduce the number of annual hospital patient deaths from medical errors.

Humana is waiving its prescription refill rule for health plan members in three Minnesota counties damaged by flooding.